Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A “Made-in-Canada” serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination

View ORCID ProfileKaren Colwill, Yannick Galipeau, Matthew Stuible, Christian Gervais, View ORCID ProfileCorey Arnold, View ORCID ProfileBhavisha Rathod, Kento T. Abe, Jenny H. Wang, Adrian Pasculescu, Mariam Maltseva, Lynda Rocheleau, View ORCID ProfileMartin Pelchat, Mahya Fazel-Zarandi, Mariam Iskilova, Miriam Barrios-Rodiles, Linda Bennett, View ORCID ProfileKevin Yau, François Cholette, Christine Mesa, Angel X. Li, Aimee Paterson, Michelle A. Hladunewich, Pamela J. Goodwin, Jeffrey L. Wrana, Steven J. Drews, Samira Mubareka, View ORCID ProfileAllison J. McGeer, John Kim, Marc-André Langlois, View ORCID ProfileAnne-Claude Gingras, View ORCID ProfileYves Durocher
doi: https://doi.org/10.1101/2021.10.25.21265476
Karen Colwill
1Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada
(PhD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Karen Colwill
Yannick Galipeau
2Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Canada
(BSc)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Stuible
3Mammalian Cell Expression, Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada
(PhD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Gervais
3Mammalian Cell Expression, Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada
(BSc)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Corey Arnold
2Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Canada
(PhD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Corey Arnold
Bhavisha Rathod
1Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada
(BSc)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bhavisha Rathod
Kento T. Abe
1Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada
4Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada
(BSc)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jenny H. Wang
1Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada
(MSc)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrian Pasculescu
1Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada
(PhD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariam Maltseva
2Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Canada
(MSc)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lynda Rocheleau
2Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Canada
(BSc)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Pelchat
2Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Canada
5The Centre for Infection, Immunity, and Inflammation, University of Ottawa, Ottawa, Canada
(PhD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Martin Pelchat
Mahya Fazel-Zarandi
1Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariam Iskilova
1Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada
(MSc)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miriam Barrios-Rodiles
1Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada
(PhD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda Bennett
1Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada
(BSc)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin Yau
6Division of Nephrology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
(MD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kevin Yau
François Cholette
7National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada
(MPH)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine Mesa
7National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada
8Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB
(MSc)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angel X. Li
9Lunenfeld-Tanenbaum Research Institute and Department of Microbiology, at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada
(MSc)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aimee Paterson
9Lunenfeld-Tanenbaum Research Institute and Department of Microbiology, at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada
(MSc)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle A. Hladunewich
6Division of Nephrology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
(MD, MSc)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pamela J. Goodwin
1Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada
10Department of Medicine, University of Toronto, Toronto, ON, Canada
(MD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey L. Wrana
1Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada
4Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada
(PhD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven J. Drews
11Canadian Blood Services, Microbiology, Donation Policy and Studies, Edmonton, AB & Department of Laboratory Medicine and Pathology, Division of Diagnostic and Applied Microbiology, University of Alberta, Edmonton, AB, Canada
(PhD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samira Mubareka
12Department of Laboratory Medicine and Molecular Diagnostics, Division of Microbiology, Sunnybrook Health Sciences Centre; Biological Sciences, Sunnybrook Research Institute; and Division of Infectious Diseases, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
13Department of Laboratory Medicine and Pathology, University of Toronto, Toronto, ON, Canada
(MD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allison J. McGeer
9Lunenfeld-Tanenbaum Research Institute and Department of Microbiology, at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada
14Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
(MD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Allison J. McGeer
John Kim
8Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB
(PhD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc-André Langlois
2Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Canada
5The Centre for Infection, Immunity, and Inflammation, University of Ottawa, Ottawa, Canada
(PhD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: langlois@uottawa.ca gingras@lunenfeld.ca yves.durocher@cnrc-nrc.gc.ca
Anne-Claude Gingras
1Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada
4Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada
(PhD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anne-Claude Gingras
  • For correspondence: langlois@uottawa.ca gingras@lunenfeld.ca yves.durocher@cnrc-nrc.gc.ca
Yves Durocher
3Mammalian Cell Expression, Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada
(PhD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yves Durocher
  • For correspondence: langlois@uottawa.ca gingras@lunenfeld.ca yves.durocher@cnrc-nrc.gc.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

BACKGROUND Testing for antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been instrumental in detecting previous exposures and analyzing vaccine-elicited immune responses. Here, we describe a scalable “Made-in-Canada” solution that can detect and quantify SARS-CoV-2 antibodies, discriminate between natural infection- and vaccination-induced responses, and assess antibody-mediated inhibition of the spike-angiotensin converting enzyme 2 (ACE2) interaction.

METHODS We developed a set of methods and reagents to detect SARS-CoV-2 antibodies by enzyme-linked immunosorbent assay (ELISA). The main assays focus on the parallel detection of immunoglobulin (Ig)Gs against the spike trimer, its receptor binding domain (RBD), and the nucleocapsid (N) protein. These antigens are complemented by a detection antibody (human anti-IgG fused to horseradish peroxidase (HRP)) and a positive control reference antibody (recombinant IgG against the RBD), permitting intra- and inter-laboratory comparisons. Using this toolkit and commercial reagents, we optimized automated ELISAs on two different high throughput platforms to measure antibody responses to SARS-CoV-2 antigens. The assays were calibrated to a reference standard from the World Health Organization. We also automated a surrogate neutralization (sn)ELISA that measures inhibition of ACE2-Spike or -RBD interactions by antibodies using biotinylated ACE2.

RESULTS Our individual IgG-based ELISAs measure antibody levels in single-point measurements in reference to a standard antibody curve to accurately distinguish non-infected and infected individuals (area under the curve > 0.96 for each assay). Positivity thresholds can be established in individual assays using precision-recall analysis (e.g., by fixing the false positive rate), or more stringently, by scoring against the distribution of the means of negative samples across multiple assays performed over several months. For seroprevalence assessment (in a non-vaccinated cohort), classifying a sample as positive if antibodies were detected for at least 2 of the 3 antigens provided the highest specificity. In vaccinated cohorts, increases in anti-spike and -RBD (but not -N) antibodies are observed. Here, we present detailed protocols to perform these assays using either serum/plasma or dried blood spots both manually and on two automated platforms, and to express the results in international units to facilitate data harmonization and inter-study comparisons. We also demonstrate that the snELISA can be performed automatically at single points, increasing the scalability of this functional assay for large seroprevalence studies.

INTERPRETATION The ability to measure antibodies to three viral antigens and identify neutralizing antibodies capable of disrupting spike-ACE2 interactions in high-throughput assays enables large-scale analyses of humoral immune responses to SARS-CoV-2 infection and vaccination. The “Made-in-Canada” set of protein reagents, produced at the National Research Council of Canada are publicly available to enable the up-scaling of standardized serological assays, permitting nationwide data comparison and aggregation.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

We acknowledge support from Ontario Together and funding from the Canadian Institutes of Health Research (CIHR; #VR1-172711 and #439999) and the COVID-19 Immunity Task Force (CITF). We also acknowledge financial support from the NRC Pandemic Response Challenge Program. Funding for initial assay development in the Gingras lab was provided through generous donations from the Royal Bank of Canada and the Krembil Foundation to the Sinai Health System Foundation. The robotics equipment used is housed in the Network Biology Collaborative Centre at the LTRI, a facility supported by the Canada Foundation for Innovation, the Ontario Government, and Genome Canada and Ontario Genomics (OGI-139). Assay development in the Langlois lab and the purchase of robotic equipment was supported by a grant from the CIHR (#VR2-172722) and supplemental funding from the CITF. Kento T. Abe was a recipient of an Ontario Graduate Scholarship and is supported by a CIHR CGS-D studentship. Mariam Maltseva holds a Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-GSST).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Research Ethics Board of Mount Sinai Hospital (Toronto, ON) gave ethics approval for performing ELISA assays with samples collected across several studies (study number: #20-0078-E). The Research Ethics Board of Mount Sinai Hospital also gave ethics approval for sample collection and analysis (studies #02-0118-U/05-0016-C, #01-0138-U, #20-0144-A, #21-0049-E and #01-0347-U). The Research Ethics Board of the Unity Health Network (Toronto, ON) gave ethics approval for sample collection and analysis (study #20-044). The Research Ethics Board of Sunnybrook Health Sciences Centre gave ethics approval for sample collection and analysis (study #4814). The British Columbia Childrens Hospital Biobank (BCCHB) in Vancouver, BC, Canada gave approval sample collection and analysis (REB#: H-07-20-6009). The University of Ottawa gave ethics approval for sample collection and analysis (REB # H-04-20-5727, # H-11-20-6172 and REB # H-09-20-6135).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • The authors declare no competing interests

  • Funding: We acknowledge support from Ontario Together and funding from the Canadian Institutes of Health Research (CIHR; #VR1-172711 and #439999) and the COVID-19 Immunity Task Force (CITF). We also acknowledge financial support from the NRC’s Pandemic Response Challenge Program. Funding for initial assay development in the Gingras lab was provided through generous donations from the Royal Bank of Canada and the Krembil Foundation to the Sinai Health System Foundation. The robotics equipment used is housed in the Network Biology Collaborative Centre at the LTRI, a facility supported by the Canada Foundation for Innovation, the Ontario Government, and Genome Canada and Ontario Genomics (OGI-139). Assay development in the Langlois lab and the purchase of robotic equipment was supported by a grant from the CIHR (#VR2-172722) and supplemental funding from the CITF. Kento T. Abe was a recipient of an Ontario Graduate Scholarship and is supported by a CIHR CGS-D studentship. Mariam Maltseva holds a Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-GSST).

Data Availability

This is a methods development manuscript. REAGENT ACCESS: The reagents produced by the NRC and qualified as reference materials (SMT1-1, N and hACE2-BAP) are available through the Metrology Research Centre Virtual Store (Virtual Store - National Research Council Canada: Products in Category Proteins (nrc-cnrc.gc.ca)). A limited panel of matched plasma and DBS is available upon request

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 26, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A “Made-in-Canada” serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A “Made-in-Canada” serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination
Karen Colwill, Yannick Galipeau, Matthew Stuible, Christian Gervais, Corey Arnold, Bhavisha Rathod, Kento T. Abe, Jenny H. Wang, Adrian Pasculescu, Mariam Maltseva, Lynda Rocheleau, Martin Pelchat, Mahya Fazel-Zarandi, Mariam Iskilova, Miriam Barrios-Rodiles, Linda Bennett, Kevin Yau, François Cholette, Christine Mesa, Angel X. Li, Aimee Paterson, Michelle A. Hladunewich, Pamela J. Goodwin, Jeffrey L. Wrana, Steven J. Drews, Samira Mubareka, Allison J. McGeer, John Kim, Marc-André Langlois, Anne-Claude Gingras, Yves Durocher
medRxiv 2021.10.25.21265476; doi: https://doi.org/10.1101/2021.10.25.21265476
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
A “Made-in-Canada” serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination
Karen Colwill, Yannick Galipeau, Matthew Stuible, Christian Gervais, Corey Arnold, Bhavisha Rathod, Kento T. Abe, Jenny H. Wang, Adrian Pasculescu, Mariam Maltseva, Lynda Rocheleau, Martin Pelchat, Mahya Fazel-Zarandi, Mariam Iskilova, Miriam Barrios-Rodiles, Linda Bennett, Kevin Yau, François Cholette, Christine Mesa, Angel X. Li, Aimee Paterson, Michelle A. Hladunewich, Pamela J. Goodwin, Jeffrey L. Wrana, Steven J. Drews, Samira Mubareka, Allison J. McGeer, John Kim, Marc-André Langlois, Anne-Claude Gingras, Yves Durocher
medRxiv 2021.10.25.21265476; doi: https://doi.org/10.1101/2021.10.25.21265476

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (579)
  • Anesthesia (139)
  • Cardiovascular Medicine (1947)
  • Dentistry and Oral Medicine (252)
  • Dermatology (184)
  • Emergency Medicine (333)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (699)
  • Epidemiology (11102)
  • Forensic Medicine (8)
  • Gastroenterology (624)
  • Genetic and Genomic Medicine (3168)
  • Geriatric Medicine (308)
  • Health Economics (561)
  • Health Informatics (2042)
  • Health Policy (863)
  • Health Systems and Quality Improvement (782)
  • Hematology (310)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12720)
  • Intensive Care and Critical Care Medicine (707)
  • Medical Education (317)
  • Medical Ethics (92)
  • Nephrology (334)
  • Neurology (2986)
  • Nursing (164)
  • Nutrition (463)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1552)
  • Ophthalmology (477)
  • Orthopedics (185)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (403)
  • Pediatrics (912)
  • Pharmacology and Therapeutics (381)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2785)
  • Public and Global Health (5591)
  • Radiology and Imaging (1094)
  • Rehabilitation Medicine and Physical Therapy (635)
  • Respiratory Medicine (760)
  • Rheumatology (338)
  • Sexual and Reproductive Health (311)
  • Sports Medicine (289)
  • Surgery (343)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (132)